Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
Even C, Wang HM, Li SH, Ngan RK, Dechaphunkul A, Zhang L, Yen CJ, Chan PC, Chakrabandhu S, Ma BBY, Tanasanvimon S, Lee VHF, Lou PJ, Li Z, Spira AI, Sukari A, Guigay J, McCune S, Gonzalez-Maffe J, Szpakowski S, Yao Y, Liang H, Mataraza J, Séchaud R, Manenti L, Lim DW. Even C, et al. Among authors: lou pj. Clin Cancer Res. 2021 Dec 1;27(23):6413-6423. doi: 10.1158/1078-0432.CCR-21-0822. Epub 2021 Aug 25. Clin Cancer Res. 2021. PMID: 34433653 Clinical Trial.
Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.
Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Coghill AE, et al. Among authors: lou pj. Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4. Clin Cancer Res. 2018. PMID: 29301829 Free PMC article.
Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis.
Hsu WL, Chien YC, Huang YT, Yu KJ, Ko JY, Lin CY, Tsou YA, Leu YS, Liao LJ, Chang YL, Su JY, Liu Z, Wang CP, Terng SD, Hua CH, Lee JC, Yang TL, Kate Hsiao CH, Wu MS, Tsai MH, Liu MJ, Lou PJ, Hildesheim A, Chen CJ; GEV-NPC Study Group. Hsu WL, et al. Among authors: lou pj. Cancer Med. 2020 Mar;9(5):1867-1876. doi: 10.1002/cam4.2832. Epub 2020 Jan 10. Cancer Med. 2020. PMID: 31925935 Free PMC article.
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions.
Lam WKJ, King AD, Miller JA, Liu Z, Yu KJ, Chua MLK, Ma BBY, Chen MY, Pinsky BA, Lou PJ, Woo JKS, Hsu WL, Simon J, Doolan DL, Waterboer T, Hui EP, Li H, Tsang RK, Wong KCW, Goh JP, Vlantis AC, Ai QY, Wong LM, Abdullah V, Lin JC, Chen CJ, Pfeiffer RM, Le QT, Lee AWM, Ji M, Cao S, Ma J, Chan ATC, Chan KCA, Hildesheim A. Lam WKJ, et al. Among authors: lou pj. J Natl Cancer Inst. 2023 Apr 11;115(4):355-364. doi: 10.1093/jnci/djad012. J Natl Cancer Inst. 2023. PMID: 36723440 Free PMC article.
Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08).
Wang HM, Lou PJ, Yang MH, Chen TH, Lien MY, Lin JC, Chen JP, Lu WC, Lu HJ, Huang TL, Yen CJ, Wu SY, Wang HC, Hsieh MC. Wang HM, et al. Among authors: lou pj. Target Oncol. 2024 Jan;19(1):51-58. doi: 10.1007/s11523-023-01028-7. Epub 2024 Jan 29. Target Oncol. 2024. PMID: 38285067 Free PMC article.
203 results